HIGHLIGHTS
- who: Courtney E. McAleese from the School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia have published the research: Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis, in the Journal: (JOURNAL)
- what: This study aimed to investigate in vitro using normal cell lines and NAT1-deficient cell lines to understand the changes induced by the lack of that resulted in poor response. This study was designed to investigate whether NAT1 deficiency seen in a significant proportion of breast tumours . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.